Saw Palmetto for Hair Loss: What the Trials Actually Measured

Who This Is For#

This guide is for you if:

• You have been told saw palmetto is "natural finasteride" and want to know what the trials measured
• You are weighing a supplement against a prescription for early pattern hair loss
• You want to understand why a strong laboratory result does not translate into a strong hair count
• You want the safety signals laid out plainly, including the ones that are only case reports

This guide is NOT for you if:

• Your hair is coming out in round, smooth patches: read Alopecia Areata
• Your scalp is red, scaly, painful or scarred where hair has gone: read Scarring Alopecia Types
• Your shedding is diffuse and began a few months after an illness, surgery or major stress: read Telogen Effluvium
• You want the prescription options first: read Hair Loss Medications Compared

What Saw Palmetto Is Supposed to Do#

A real enzyme effect that is not a hair count#

Pattern hair loss is driven by dihydrotestosterone (DHT) acting on genetically sensitive follicles, and DHT is made from testosterone by the enzyme 5-alpha-reductase. Finasteride blocks that enzyme; the claim for saw palmetto is that it does the same without a prescription. See DHT and Hair Loss for the biology.

The laboratory evidence is real. Wessagowit and colleagues summarize it: "Serenoa repens extract has been shown to inhibit both types of 5-α reductase and, when taken orally, has been shown to increase hair growth in AGA patients" [4]. An ex vivo study in cultured human hair follicles found a proprietary extract "exhibited a more potent 5-αR inhibition than a standard, commercially available saw palmetto extract" [10], yet its authors conclude only that "preliminary findings suggest that USPlus® DERM has the potential to promote hair growth" [10]. The enzyme data is what product pages quote; the trial data is what determines whether your hair changes.

What the Systematic Review Found#

Evron 2020: the anchor source#

The anchor synthesis is a 2020 systematic review by Evron and colleagues [1]. Its scope was modest: "Five randomized clinical trials (RCTs) and 2 prospective cohort studies demonstrated positive effects of topical and oral supplements containing SP (100-320 mg) among patients with androgenetic alopecia (AGA) and telogen effluvium" [1].

The headline figures: "Sixty percent improvement in overall hair quality, 27% improvement in total haircount, increased hair density in 83.3% of patients, and stabilized disease progression among 52% were noted with use of various topical and oral SP-containing supplements" [1]. The figures come from different products and different outcome measures, so they cannot be combined into one effect size.

The verdict is careful. On safety: "SP was well tolerated and not associated with serious adverse events in alopecia patients" [1]. On efficacy: "Although robust high-quality data are lacking, supplements containing SP may be a treatment option" [1]. On what is missing: "Further large-scale RCTs focusing on the sole contribution of SP to hair growth outcomes are needed" [1]. "Sole contribution" matters because many trials tested saw palmetto inside a multi-ingredient product.

The Head-to-Head With Finasteride#

Rossi 2012: 320 mg versus 1 mg over 24 months#

Only one located study compares saw palmetto directly with finasteride. Rossi and colleagues "enrolled 100 male patients with clinically diagnosed mild to moderate AGA" [2]. "One group received Serenoa repens 320 mg every day for 24 months, while the other received finasteride 1 mg every day for the same period" [2].

Location differed: "finasteride acts in both the front area and the vertex, while Serenoa repens prevalently in the vertex" [2].

Three limitations sit alongside those numbers. The trial was open-label, so patients and assessors knew who was taking what. There was no placebo arm, so the 38% cannot be separated from the share who would have reported improvement on nothing. And "improvement" was a proportion of patients, not a hair count. Even so, it is the only controlled comparison available, and it favors finasteride by a wide margin. For the finasteride trials themselves, see the Complete Guide to Finasteride.

The Older Trials: A Pilot and a Topical Study#

Prager 2002: the placebo-controlled pilot#

The trial usually offered as proof that saw palmetto works is small. Prager and colleagues ran "a randomized, double-blind, placebo-controlled trial" in men "with mild to moderate AGA", testing "the liposterolic extract of Serenoa repens (LSESr) and beta-sitosterol" together [3]. The result: "60% of (6/10) study subjects dosed with the active study formulation were rated as improved at the final visit" [3]. Six of ten is the whole active arm. The authors said the result "justifies the expansion to larger trials" [3]; by 2020 the large-scale, high-quality trials it called for still had not appeared [1].

Wessagowit 2016: topical saw palmetto without a placebo#

The main topical study is direct about its design: "This was a pilot, prospective, open, within-subject comparison limited to 24 weeks using no placebo controls. In all, 50 male volunteers aged between 20 and 50 years received topical S. repens products for 24 weeks" [4]. "The average hair count and terminal hair count increased at weeks 12 and 24 compared to baseline" [4], though the authors note some results "levelled off at week 24" after the concentrated product was stopped [4]. Without a placebo, an increase from baseline cannot be attributed to the product. Compare Minoxidil 5%, whose topical evidence rests on placebo-controlled hair counts.

The Newer Trials, 2023 to 2026#

Placebo-controlled at last, but mostly proprietary#

Recent years have produced placebo-controlled trials, though not the large-scale, saw-palmetto-only trials the 2020 review asked for, and they report positive results. Two features temper their weight: most test a branded extract rather than generic saw palmetto, and two of the recent studies, one placebo-controlled [5] and one add-on trial against medication alone [9], disclose author ties to the company selling the product.

In the 180-day trial the placebo arm lost hair while the active arm gained, which is what produces the large relative differences the paper reports [8]. And the adjunct trial tested a supplement containing "Serenoa repens extract, Cucurbita pepo extract, L-Cystine, and Vitamin C" added to topical minoxidil and oral finasteride [9]: an add-on, not evidence that saw palmetto replaces either drug. None of these is a large independent test of generic saw palmetto against placebo, so the gap the 2020 review identified is narrower but not closed.

Safety and the Regulation Problem#

What the trials report, and the signals outside them#

The trial record on tolerability is reassuring. The 2020 review found saw palmetto "well tolerated and not associated with serious adverse events in alopecia patients" [1]; the combination-supplement trial reported "No moderate or severe adverse events" [6], and the 180-day trial "no treatment-related adverse events" [8]. Those trials are short. Outside them, three signals:

Endocrine effects in children. Two case reports describe hot flashes in young girls given Serenoa repens; one found "a probable relationship (score of 6) between the appearance of hot flashes and the intake of S repens" [12], and the other calls for "a better evaluation of benefit/risk profile" before such agents are used in children [11].

Contact sensitization. A case report documents allergic contact sensitization to topical saw palmetto, and separately to topical minoxidil, in a woman treated for androgenetic alopecia [13].

Persistent sexual and psychiatric symptoms. A 2026 case series asks whether there is a "post-Serenoa syndrome" [14]. Adverse effects emerged "within 1 month in 61% of cases", symptoms were "severe and persistent (mean duration 4.7 years)", and dosing "ranged from 120-900 mg daily" [14]. The caveat is the source: an online forum for people already reporting persistent symptoms after finasteride and similar agents. A self-selected sample says nothing about how often this happens among all users; it is a pharmacovigilance question, not an incidence rate.

If you take any regular medicine, ask a pharmacist before adding a supplement; none of the sources behind this guide addresses drug interactions.

No label, no standardized dose#

Finasteride and minoxidil each have an FDA-approved label with a set dose, contraindications and measured adverse-reaction rates. Saw palmetto has none of that: a DailyMed search returns homeopathic multi-ingredient products and supplement capsules, none an approved drug label for any indication [15]. The doses in the literature reflect that: "100-320 mg" across the 2020 review [1], "320 mg every day" in Rossi [2], and "120-900 mg daily" in the adverse-event series [14]. A trial result for one product does not transfer to a different bottle; see Best Hair Growth Supplements.

How It Compares With Minoxidil and Finasteride#

The comparison the evidence allows#

Against finasteride, the comparison is direct and one-sided: 38% improved on Serenoa repens against 68% on finasteride over 24 months, and finasteride also worked on the frontal scalp where saw palmetto largely did not [2]. Against topical minoxidil we found no head-to-head trial; the topical saw palmetto study had no placebo [4], while minoxidil's evidence base is built on placebo-controlled hair counts. The Treatment Evidence Explorer sets the prescription options side by side, and the Androgenetic Alopecia guide covers the condition itself.

What to discuss with a clinician#

Nothing here is a reason to start, stop or swap a prescription on your own. Questions worth bringing to a dermatologist or prescriber:

• Considering saw palmetto instead of finasteride: what 38% versus 68% means for your stage, and whether the mainly-vertex effect [2] matters for a receding hairline. The Norwood scale helps you describe your stage.
• Unable or unwilling to take finasteride: topical finasteride, minoxidil, and for women the options in Female Pattern Hair Loss: Treatment Options That Work.
• Taking saw palmetto with new sexual or mood changes: tell your clinician, given the case series above [14].

Photograph your scalp under the same light each month so a later decision rests on your own data; Tracking Hair Loss Progress shows how. If hair is coming out in patches, the scalp is painful or scarred, or you have symptoms elsewhere in the body, skip the supplement question and see a dermatologist; When to See a Dermatologist for Hair Loss lists the red flags.

Frequently Asked Questions#

Related Resources#

• Complete Guide to Finasteride for Hair Loss
• Minoxidil 5% Complete Guide: How to Apply for Best Results
• DHT and Hair Loss: Complete Explanation
• Best Hair Growth Supplements: What the Evidence Actually Shows
• Hair Loss Medications: The Complete Comparison Guide
• Rosemary Oil for Hair Growth: Evidence Review
• Androgenetic Alopecia: Complete Guide
• When to See a Dermatologist for Hair Loss: Red Flags